Understanding the “Oncolytic Virus (OV) Basis & Therapy.” PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Understanding the “Oncolytic Virus (OV) Basis & Therapy.” PDF full book. Access full book title Understanding the “Oncolytic Virus (OV) Basis & Therapy.” by Dr. Hakim. K. Saboowala. Download full books in PDF and EPUB format.
Author: Dr. Hakim. K. Saboowala
Publisher: Dr.Hakim Saboowala
ISBN:
Category : Medical
Languages : en
Pages : 40
Get Book Here
Book Description
Understanding the “Oncolytic Virus (OV) Basis & Therapy.” Oncolytic viruses (OVs) are an emerging class of cancer therapeutics that offer the: · Benefits of selective replication in tumour cells, · Delivery of multiple eukaryotic transgene payloads, · Induction of immunogenic cell death and promotion of antitumour immunity, and · Tolerable safety profile that largely does not overlap with that of other cancer therapeutics. To date, four OVs and one non-oncolytic virus have been approved for the treatment of cancer globally although talimogene laherparepvec (T-VEC) remains the only widely approved therapy. Despite increasing research interest, a better understanding of the underlying biology of OVs is needed to enable the full therapeutic potential of these agents in patients with cancer. Thus, it is strived in this Booklet to precisely describe: ü Time-line History of oncolytic virus development, ü Mechanisms of Tumour Tropism, ü Mechanisms of action of virus destroying tumour cells and ü Inherent and engineered oncolytic viruses. Further, it is also attempted to describe on optimization of the use of OVs in clinical practice along with plenty of relevant IMAGES for better understanding. …Dr. H. K. Saboowala. M.B.(Bom) .M.R.S.H.(London)
Author: Dr. Hakim. K. Saboowala
Publisher: Dr.Hakim Saboowala
ISBN:
Category : Medical
Languages : en
Pages : 40
Get Book Here
Book Description
Understanding the “Oncolytic Virus (OV) Basis & Therapy.” Oncolytic viruses (OVs) are an emerging class of cancer therapeutics that offer the: · Benefits of selective replication in tumour cells, · Delivery of multiple eukaryotic transgene payloads, · Induction of immunogenic cell death and promotion of antitumour immunity, and · Tolerable safety profile that largely does not overlap with that of other cancer therapeutics. To date, four OVs and one non-oncolytic virus have been approved for the treatment of cancer globally although talimogene laherparepvec (T-VEC) remains the only widely approved therapy. Despite increasing research interest, a better understanding of the underlying biology of OVs is needed to enable the full therapeutic potential of these agents in patients with cancer. Thus, it is strived in this Booklet to precisely describe: ü Time-line History of oncolytic virus development, ü Mechanisms of Tumour Tropism, ü Mechanisms of action of virus destroying tumour cells and ü Inherent and engineered oncolytic viruses. Further, it is also attempted to describe on optimization of the use of OVs in clinical practice along with plenty of relevant IMAGES for better understanding. …Dr. H. K. Saboowala. M.B.(Bom) .M.R.S.H.(London)
Author: Benjamin Gesundheit
Publisher: Frontiers Media SA
ISBN: 2889453588
Category :
Languages : en
Pages : 195
Get Book Here
Book Description
The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. Theranostic biomarkers to monitor these therapies in clinical trials serve an important need in this innovative field and demand further research.
Author: Fouad Sabry
Publisher: One Billion Knowledgeable
ISBN:
Category : Medical
Languages : en
Pages : 288
Get Book Here
Book Description
What Is Oncolytic Virus A virus is said to be oncolytic if it targets cancer cells for infection and then proceeds to destroy those cells. As a result of the oncolysis, infected cancer cells are being eliminated, which results in the production of additional infectious virus particles called virions, which further contribute to the elimination of the residual tumor. It is believed that oncolytic viruses not only induce the direct killing of tumor cells, but also activate the host's anti-tumor immune system responses. [Citation needed] [Citation needed] In addition to this, oncolytic viruses are able to influence the microenvironment of the tumor in a variety of different ways. How You Will Benefit (I) Insights, and validations about the following topics: Chapter 1: Oncolytic virus Chapter 2: Virotherapy Chapter 3: Virus latency Chapter 4: Herpes simplex virus Chapter 5: Tony Minson Chapter 6: Genetically modified virus Chapter 7: Pelareorep Chapter 8: Pexastimogene devacirepvec Chapter 9: Herpes simplex research Chapter 10: Jennerex Chapter 11: Talimogene laherparepvec Chapter 12: Oncolytic herpes virus Chapter 13: Oncolytic adenovirus Chapter 14: GL-ONC1 Chapter 15: Genelux Corporation Chapter 16: ONCOS-102 Chapter 17: Akseli Hemminki Chapter 18: Infected cell protein 34.5 Chapter 19: Oncolytic AAV Chapter 20: HSV epigenetics Chapter 21: Transgene (company) (II) Answering the public top questions about oncolytic virus. (III) Real world examples for the usage of oncolytic virus in many fields. (IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of oncolytic virus' technologies. Who This Book Is For Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of oncolytic virus.
Author: R. C. Sobti
Publisher: Springer Nature
ISBN: 9819962633
Category :
Languages : en
Pages : 1584
Get Book Here
Book Description
Author: Phonphimon Wongthida
Publisher:
ISBN:
Category :
Languages : en
Pages : 356
Get Book Here
Book Description
Author: Edmund C. Lattime
Publisher: Academic Press
ISBN: 0123946328
Category : Medical
Languages : en
Pages : 554
Get Book Here
Book Description
Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive. Cancer gene therapy, like cancer therapy in general, is evolving rapidly, testing new concepts, targets and pathways, evoking new technologies, and passing new regulatory hurdles. Its essence, however, has not changed: the hope and challenges of returning altered genes to normal, using targeted gene expression to alter the function of both tumor and microenvironment, and in some cases normal cells, and delivering functionally important genes to specific cell types to increase sensitivity to killing or to protect normal cells from cancer therapies. In some instances, gene therapy for cancer forms a continuum from gene repair through the use of molecularly modified cells; the use of viral and non-viral vector based gene delivery to both tumor and tumor microenvironment; the use of viral and gene based vaccines; and development of new gene-based therapeutics. The unique mechanistically chosen vector platforms are at the heart of this technology because they allow for direct and selective cell death and transient to sustained delivery of vaccine molecules or molecules that affect the microenvironment, vasculature, or the immune response. Explains the underlying cancer biology necessary for understanding proposed therapeutic approaches Presents in-depth description of targeting systems and treatment strategies Covers the breadth of gene therapy approaches including immunotherapeutic, drug resistance,oncolytic viruses, as well as regulatory perspectives from both the NCI and FDA
Author: Fouad Sabry
Publisher: One Billion Knowledgeable
ISBN:
Category : Medical
Languages : en
Pages : 363
Get Book Here
Book Description
What Is Virotherapy Reprogramming viruses in order to cure illness is an example of virotherapy, which is a kind of treatment that makes use of biotechnology to turn viruses into therapeutic agents. Anti-cancer oncolytic viruses, viral vectors for gene therapy, and viral immunotherapy are the three primary subspecialties that fall under the umbrella term "virotherapy." Gene overexpression, gene knockout, and suicide gene delivery are the three distinct approaches that are used by these branches throughout the therapeutic process. Gene overexpression results in the addition of genetic sequences that make up for insufficient or nonexistent amounts of essential gene expression. Gene silencing or expression reduction may be achieved by gene deletion by using RNA-based techniques. The delivery of suicide genes involves the introduction of genetic sequences that trigger an apoptotic response in cells; this is often done in order to eliminate malignant growths. In a somewhat different setting, the term "virotherapy" may also refer to the use of viruses to cure certain medical problems by eliminating infections. This is one definition of the term. How You Will Benefit (I) Insights, and validations about the following topics: Chapter 1: Virotherapy Chapter 2: Gene therapy Chapter 3: Immunotherapy Chapter 4: Cancer vaccine Chapter 5: Chimeric antigen receptor T cell Chapter 6: Cancer immunotherapy Chapter 7: Oncolytic virus Chapter 8: Viral vector Chapter 9: Murine respirovirus Chapter 10: Oncolytics Biotech Chapter 11: Pelareorep Chapter 12: Molecular oncology Chapter 13: Pexastimogene devacirepvec Chapter 14: Talimogene laherparepvec Chapter 15: Oncolytic herpes virus Chapter 16: Oncolytic adenovirus Chapter 17: Measles virus encoding the human thyroidal sodium iodide symporter Chapter 18: Timeline of cancer treatment development Chapter 19: Julianna Lisziewicz Chapter 20: Oncolytic AAV Chapter 21: Viral vector vaccine (II) Answering the public top questions about virotherapy. (III) Real world examples for the usage of virotherapy in many fields. (IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of virotherapy' technologies. Who This Book Is For Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of virotherapy.
Author: Kevin J. Harrington
Publisher: John Wiley & Sons
ISBN: 047098578X
Category : Science
Languages : en
Pages : 432
Get Book Here
Book Description
In the last decade there has been an explosion of interest in viral therapies for cancer. Viral agents have been developed that are harmless to normal tissues but selectively able to kill cancer cells. These agents have been endowed with additional selectivity and potency through genetic manipulation. Increasingly these viruses are undergoing evaluation in clinical trials, both as single agents and in combination with standard chemotherapy and radiotherapy. This book provides a comprehensive yet succinct overview of the current status of viral therapy of cancer. Chapters coherently present the advances made with individual agents and review the biological and clinical background to a range of viral therapies: structured to proceed from basic science at the bench to the patient’s bedside, they give an up-to-date and realistic evaluation of a therapy’s potential utility for the cancer patient. Presents state of the art knowledge on how viruses can be, and have been, used in novel therapeutic approaches for the treatment of cancer Describes the use of viruses as oncolytic agents, killing cells directly Editors are experts in the field, with experience of both laboratory and clinical research Viral Therapy of Cancer is essential reading for both basic scientists and clinicians with an interest in viral therapy and gene therapy.
Author: Philippe Fournier
Publisher: Frontiers Media SA
ISBN: 2889194507
Category : Cancer
Languages : en
Pages : 111
Get Book Here
Book Description
Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-oncolytic immune response continues to mediate tumor destruction and retards progression of the disease. For a long time, the therapeutic efficacy was thought to depend mainly on the direct viral oncolysis based on their tumor selective replication and killing activities. But the post-oncolytic anti-tumor activity induced by the OV therapy is also a key factor for an efficient therapeutic activity. The topic adresses various strategies how to optimize OVs anti-tumor activity.
Author: Xin-Yuan Liu
Publisher: Elsevier
ISBN: 012397836X
Category : Medical
Languages : en
Pages : 701
Get Book Here
Book Description
Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super Interferon, HecI based and liposome based therapy, gene therapy, and p53 based cancer therapy. There is also a discussion of current cancer research in China including traditional Chinese medicine. Written by leading scientists in the field, this book provides an essential insight into the current state of cancer therapy and treatment. Includes a wide range of research areas including a focus on biotherapy and the development of novel cancer therapeutic strategies. Formatted for a broad audience including all working in researching cancer treatments and therapies. Discusses special traits and results of Chinese cancer research.
